FLR vs VRTX · P/E 22, rev $7.99B vs P/E 30, rev $3.33B
Fluor Corporation (FLR) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Fluor Corporation (FLR) is a engineering & construction company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported FLR revenue for 2026-06-30 was $7.99B. Net income was $274.0M. FLR currently screens at market cap $6.64B and trailing P/E 21.7.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
FLR currently screens at market cap $6.64B and trailing P/E 21.7. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the FLR and VRTX stock pages for the full models.
Not investment advice.